Vaxart, Inc. (VXRT) financial statements (2021 and earlier)

Company profile

Business Address 385 OYSTER POINT BOULEVARD, SUITE 9A
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments127141239695882
Cash and cash equivalents127141218504582
Short-term investments   211913 
Receivables042112520
Contract with customer, asset 0 
Other undisclosed current assets10113(12)(0)
Total current assets:1291815407271101
Noncurrent Assets
Operating lease, right-of-use asset72
Property, plant and equipment1010002
Long-term investments and receivables     810
Long-term investments     810
Intangible assets, net (including goodwill)151719   
Intangible assets, net (excluding goodwill)151719    
Other noncurrent assets000    
Deferred tax assets, net   11
Total noncurrent assets:24192100913
TOTAL ASSETS:1533735407379114
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:75248826
Accounts payable2111423
Accrued liabilities5523453
Employee-related liabilities     20
Other undisclosed accounts payable and accrued liabilities     (1)19
Debt 1 000 
Deferred revenue and credits11  
Deferred tax liabilities   11
Other undisclosed current liabilities535    
Total current liabilities:129769927
Noncurrent Liabilities
Long-term debt and lease obligation512001 
Long-term debt, excluding current maturities  2001 
Operating lease, liability51
Liabilities, other than long-term debt00015170(1)
Deferred revenue and credits1517  
Deferred tax liabilities, net    (1)
Other liabilities0000000
Other undisclosed noncurrent liabilities121314   1
Total noncurrent liabilities:171517161710
Total liabilities:29242421271027
Stockholders' equity
Stockholders' equity attributable to parent123131119467087
Common stock0514444
Additional paid in capital272125109160158156146
Accumulated other comprehensive income   19191927
Accumulated deficit(149)(117)(98)(164)(134)(109)(90)
Total stockholders' equity:123131119467087
TOTAL LIABILITIES AND EQUITY:1533735407379114

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Revenues4104992569
Revenue, net692569
Cost of revenue
(Cost of Goods and Services Sold)
     (4)(51)
Gross profit:4104992118
Operating expenses(34)(26)(26)(36)(35)(54)(90)
Other undisclosed operating income     1361
Operating loss:(30)(16)(22)(28)(25)(20)(12)
Nonoperating income (expense)(0)(2)4(2)(0)00
Investment income, nonoperating  7    
Foreign currency transaction gain (loss), before tax(0)(0)(0)  7(1)
Other nonoperating income   000 
Interest and debt expense (0)(1)    
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes(2)01    
Loss from continuing operations before income taxes:(32)(18)(18)(29)(25)(19)(11)
Income tax expense (benefit)(0)(0)(0)(0) 00
Net loss attributable to parent:(32)(19)(18)(29)(25)(19)(11)
Preferred stock dividends and other adjustments  (0)    
Net loss available to common stockholders, diluted:(32)(19)(18)(29)(25)(19)(11)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Net loss:(32)(19)(18)(29)(25)(19)(11)
Comprehensive loss:(32)(19)(18)(29)(25)(19)(11)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent    0(8)2
Comprehensive loss, net of tax, attributable to parent:(32)(19)(18)(29)(25)(27)(10)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: